POS0624 EFFICACY AND SAFETY OF LEVILIMAB IN COMBINATION WITH METHOTREXATE IN SUBJECTS WITH ACTIVE RHEUMATOID ARTHRITIS: PHASE III, DOUBLE-BLIND, PLACEBO-CONTROLLED, RANDOMIZED TRIAL - Mazurov, V.; Korolev, M.; Kundzer, A.; Soroka, N.; Kastanayan, A.; Povarova, T.; Plaksina, T.; Antipova, O.; Kretchikova, D.; Smakotina, S.; Tciupa, O.; Raskina, T.; et al. (Annals of the rheumatic diseases, 2021)
Keywords: Adverse events; Bilirubin; Blood; Cell number; Cholesterol; Clinical trials; Double-blind studies; Interleukin 6; Interleukin 6 receptors; Joint diseases; Lymphocytes; Methotrexate; Placebos; Rheumatoid arthritis; Safety; Triglycerides; Tuberculosis